Harvard Bioscience Inc. (NASDAQ: HBIO)
$2.2500
+0.0900 ( +2.74% ) 111.1K
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
Market Data
Open
$2.2500
Previous close
$2.1600
Volume
111.1K
Market cap
$96.63M
Day range
$2.1600 - $2.2400
52 week range
$1.9900 - $5.5600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | May 14, 2024 |
10-q | Quarterly Reports | 85 | May 07, 2024 |
8-k | 8K-related | 15 | May 07, 2024 |
8-k | 8K-related | 14 | Apr 03, 2024 |
def | Proxies and info statements | 5 | Apr 03, 2024 |
ars | Annual reports | 1 | Apr 03, 2024 |
8-k | 8K-related | 13 | Mar 26, 2024 |
10-k | Annual reports | 117 | Mar 07, 2024 |
8-k | 8K-related | 16 | Mar 07, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |